Please login to the form below

Not currently logged in
Email:
Password:

Respimat inhaler

This page shows the latest Respimat inhaler news and features for those working in and with pharma, biotech and healthcare.

Boehringer to add wireless data-collection to its Respimat inhaler

Boehringer to add wireless data-collection to its Respimat inhaler

Boehringer to add wireless data-collection to its Respimat inhaler. Joins forces with Qualcomm for COPD adherence collaboration. ... The collaboration looks to develop a fully-integrated data-capturing module for Respimat - Boehringer Ingelheim's

Latest news

  • Boehringer to target COPD adherence Boehringer to target COPD adherence

    The deal will see people living with COPD and asthma and treated with a Boehringer medication that can be used in its Respimat inhaler offered the opportunity to enrol - via select ... This is designed to determine how Propeller's novel health

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • 2016: The year when deal-makers took stock? 2016: The year when deal-makers took stock?

    Another digital deal was Boehringer Ingelheim's collaboration with Qualcomm to develop a small wireless disposable module for the Respimat inhaler that will track puffs from the inhaler to help healthcare

  • Deal Watch August 2016 Deal Watch August 2016

    Another digital deal in August was Boehringer Ingelheim's collaboration with Qualcomm to develop a small wireless disposable module for the Respimat inhaler that will track puffs from the inhaler to

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hive

We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics